1. Home
  2. CRNT vs ABOS Comparison

CRNT vs ABOS Comparison

Compare CRNT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.66

Market Cap

228.1M

Sector

Technology

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.52

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
ABOS
Founded
1996
1996
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.1M
182.0M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
CRNT
ABOS
Price
$2.66
$2.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$3.50
$8.00
AVG Volume (30 Days)
539.1K
292.3K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.11
N/A
Revenue Next Year
$6.70
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.82
$0.99
52 Week High
$2.84
$3.60

Technical Indicators

Market Signals
Indicator
CRNT
ABOS
Relative Strength Index (RSI) 57.47 51.64
Support Level $2.30 $2.24
Resistance Level $2.82 $2.77
Average True Range (ATR) 0.15 0.14
MACD -0.01 0.01
Stochastic Oscillator 65.52 66.41

Price Performance

Historical Comparison
CRNT
ABOS

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: